Cite
HARVARD Citation
Yao, M. et al. (2022). Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia. Medicine. 101 (4), pp. e28679-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yao, M. et al. (2022). Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia. Medicine. 101 (4), pp. e28679-. [Online].